Skip to main content
. 2018 Jul 27;34(4):261–268. doi: 10.1159/000491107

Table 1.

Recommended antibiotic treatment according to Jalan et al. [3]

Site of infection Community-acquired Nosocomial
SBP, SBE, spontaneous bacteremia cefotaxime or ceftriaxone or amoxicillin/clavulanic acid piperacillin/tazobactam or meropenem ± glycopeptide

Urinary tract infection uncomplicated:
ciprofloxacin or cotrimoxazole
sepsis:
cefotaxime or ceftriaxone or
amoxicillin/clavulanic acid
uncomplicated:
Nitrofurantoin or fosfomycine
sepsis:
Piperacillin/tazobactam or
meropenem ± glycopeptide
Pneumonia amoxicillin/clavulanic acid or
ceftriaxone + macrolide or
levofloxacin or moxifloxacin
piperacillin/tazobactam or
meropenem/ceftazidime +
ciprofloxacin
glycopeptides when high risk
for MRSA
Cellulitis amoxicillin/clavulanic acid or ceftriaxone + oxacillin meropenem/ceftazidime + oxacillin or glycopeptides

MRSA = Methicillin-resistant Staphylococcus aureus; SBE = spontaneous bacterial empyema; SBP = spontaneous bacterial peritonitis.